Developer docs
API playgroundTry for free, no card

Search company profiles

Molecular Loop

Full company profile

uuid0003kvy

Namestring
Molecular Loop
Legal namestring
Molecular Loop Biosciences, Inc.
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Molecular Loop Biosciences, Inc. is a private Woburn, Massachusetts-based biotechnology company (founded 2018, 11–50 employees) that develops and sells targeted next-generation sequencing (NGS) reagents built around its proprietary LoopCap™ molecular inversion probe (MIP) chemistry. LoopCap combines target capture and library preparation into a single-tube, 4-step workflow with roughly 75 minutes of hands-on time and uses redundant probe tiling with non-overlapping priming sites to provide variant resilience against rapidly mutating pathogens. The company sells predesigned Viral RNA Target Capture Kits (SARS-CoV-2, RSV A/B, Hantavirus, Flu A/B incl. H5N1, HIV-2, Measles, Mumps, Powassan/deer tick virus, pan-viral/respiratory surveillance), a Viral DNA Target Capture Kit (mpox), an Inherited Disease research line, custom panel design services, and required Index Primer accessory kits, with products supporting Illumina, PacBio, and Oxford Nanopore sequencing platforms.

The business model is primarily a one-time-purchase NGS reagent sale priced at $7,815 per 96-reaction capture kit, $835 per Index Primer plate, and $3,000 per custom panel design unit, distributed through a direct e-commerce storefront at molecularloop.com with FedEx overnight cold-chain shipping. Distribution is supplemented by an exclusive Canadian agreement with D-MARK Biosciences (April 2023) and a manufacturing partnership with Watchmaker Genomics (May 2021) for enzyme formulations and scaled production. Marketing is anchored on conference participation (ASHG, AMP, AGBT, AACR, ACMG, APHL), the company website, and PRNewswire-distributed press releases.

Molecular Loop's customers include reference labs (notably Labcorp, which deployed its SARS-CoV-2 Research Sequencing Panel for CDC-affiliated surveillance), academic medical centers (Stanford, UC Davis, Northern Arizona University), and genomics research institutions (New York Genome Center, TGen North). The company remains Research Use Only, has not pursued diagnostic claims, and has secured a $1.8M Bill & Melinda Gates Foundation grant (December 2023) to extend multi-pathogen surveillance products into low- and middle-income countries. Total disclosed funding is approximately $4.3M across a 2019 raise, a 2022 exempt securities offering (~$2.5M filed / ~$1.79M sold), and the 2023 Gates grant.

Short descriptiontext

Molecular Loop develops and sells LoopCap™ molecular inversion probe-based targeted NGS reagent kits, serving infectious disease surveillance labs, academic genomic researchers, and reference labs (including Labcorp) with pathogen capture kits and custom panel design services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWoburn, United States
HQ citystring
Woburn
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
targeted sequencing kits, NGS capture reagents, molecular inversion probes, pathogen surveillance panels, custom NGS panels
Industry2 codes
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
NGS Target Capture Reagents
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1NGS Capture Kit Sales
TypeOne Time License
Description

Molecular Loop sells targeted sequencing reagent kits (capture kits) primarily as one-time purchases. Products include Viral RNA Target Capture Kits, Viral DNA Target Capture Kits, and Custom Panel Design services. Kits are sold in 96-reaction pack sizes, priced per kit. Additional accessories such as Index Primer Kits are sold separately.

molecularloop.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
Pricing details4 tiers
1Viral RNA Target Capture Kits (predesigned panels)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Viral RNA Target Capture Kit, 96 reactions: $7,815.00 per kit. Includes predesigned panels for SARS-CoV-2, RSV A/B, Flu A/B incl. H5N1, Flu H5N1, Mumps, Measles, HIV-2, Hantavirus, Pan-Viral Surveillance Panel, Respiratory Virus Surveillance Panel, Powassan/deer tick virus, and custom panels.

molecularloop.com
2Viral DNA Target Capture Kits
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Viral DNA Target Capture Kit (mpox/Illumina), 96 reactions: $7,815.00 per kit.

molecularloop.com
3Custom Panel Design
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Custom panel design, per unit: $3,000.00. Contact required to determine number of units for a project. Typical 6-week turnaround time.

molecularloop.com
4Index Primer Kits (UDI plates)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Index Primer Kit, Plate 1, Illumina (96 pre-mixed unique dual indices): $835.00 per single-use plate.

molecularloop.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Molecular Loop develops and sells targeted next-generation sequencing (NGS) reagent kits built on its proprietary LoopCap molecular inversion probe (MIP) chemistry, which combines target capture and library preparation into a single-tube workflow. The product line consists of predesigned Viral RNA and Viral DNA Target Capture Kits for specific pathogens (SARS-CoV-2, RSV A/B, influenza incl. H5N1, mpox, HIV-2, measles, mumps, hantavirus, Powassan, and pan-viral/respiratory surveillance panels), required Index Primer Kit accessories, and a Custom Panel Design service for viral genomes and germline targets.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 96% on-target rate achieved on first-pass design of a 1 Mbp panel covering 339 full genes including 5' UTRs
+4 more records
Product overview1 text field

Molecular Loop offers a portfolio of targeted NGS products centered on its proprietary LoopCap™ technology, which combines target capture and library preparation into a simplified 4-step workflow. The core offering includes pre-designed Viral RNA and DNA Target Capture Kits for specific pathogens (SARS-CoV-2, RSV A/B, Hantavirus, influenza variants including H5N1, HIV-2, Measles, Mumps, Powassan/deer tick virus, mpox) and a Pan-Viral/Respiratory Virus Surveillance Panel for multi-pathogen detection. Custom panel design services allow customers to create tailor-made assays for any viral genome or germline targets. Products are available for Illumina, PacBio, and Oxford Nanopore sequencing platforms. Required accessories include Index Primer Kits for multiplexing. The company also offers Inherited Disease research panels with flexible sizing from few targets to hundreds of genes.

Product and service1 record
1Viral RNA Target Capture Kit, SARS-CoV-2, Illumina
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1D-MARK Biosciences
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-04-10
Description

Exclusive distribution agreement making D-MARK Biosciences the sole distributor of LoopCap technology throughout Canada. D-MARK is a leading distributor of Genomic Workflow products and services in Canada with extensive relationships with genomic scientists and a strong reputation in the scientific research community.

molecularloop.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-05-04
Description

Partnership to accelerate commercialization of streamlined, high-stringency genetic testing for pathogen surveillance. Watchmaker brings expertise in computational biology, high-throughput enzyme engineering, and large-scale enzyme production to further enable Molecular Loop's advanced assay technologies. The collaboration enabled the launch of Molecular Loop's comprehensive SARS-CoV-2 Research Panel with customized enzyme formulations and scaled manufacturing.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Roche — through Roche Molecular Diagnostics (former employer of Molecular Loop board member Paul Brown) — is a broad incumbent in molecular diagnostics and NGS-based clinical assays. It does not directly sell targeted NGS capture kits at research scale but represents the eventual clinical-diagnostics competitor Molecular Loop might face or partner with.

TypeDirect peer
Description

IDT (a Danaher company) sells the xGen suite of hybridization capture and library prep reagents for targeted NGS. Its research-use kits for viral surveillance (including SARS-CoV-2) and germline panels compete head-to-head with Molecular Loop's viral capture kits.

TypeDirect peer
Description

Agilent's SureSelect target-enrichment platform is a leading NGS capture chemistry used in inherited disease, oncology, and infectious disease research. Molecular Loop competes with SureSelect on customizable, scalable targeted sequencing panels for similar end customers.

TypeDirect peer
Description

Twist develops synthetic DNA-based target enrichment and library preparation kits for NGS workflows sold to research and clinical labs. Both companies sell NGS capture panels to infectious disease and inherited disease researchers, making Twist the closest direct peer to Molecular Loop's LoopCap kits.

TypeDirect peer
Description

NEB's NEBNext product line covers DNA and RNA library prep and target enrichment reagents used by the same research and clinical genomics labs as Molecular Loop. Both vendors supply RUO capture and library prep kits for viral pathogen sequencing.

TypeBroad incumbent
Description

Illumina dominates the sequencing platform layer that Molecular Loop's kits feed into (Illumina, alongside PacBio and ONT). Illumina also offers AmpliSeq and other library prep reagents that overlap with LoopCap's amplicon/capture use cases, making it both an ecosystem enabler and competitor.

TypeBroad incumbent
Description

QIAGEN offers a broad portfolio of sample prep, target enrichment (QIAseq), and NGS reagent kits serving the same infectious disease and inherited disease research customers as Molecular Loop. It overlaps with Molecular Loop's library prep and capture workflows as part of a much broader life-science tools portfolio.

TypeBroad incumbent
Description

Thermo Fisher's Ion Torrent sequencing and Applied Biosystems/Invitrogen reagents for NGS library prep and target enrichment compete in the same RUO research workflow as Molecular Loop's kits, though as part of an enormously broader life-sciences portfolio.

9PerkinElmer / Revvity
TypeBroad incumbent
Description

Revvity (formerly PerkinElmer's life sciences business) supplies genomics reagents, including target enrichment and library prep kits, alongside broader life-science tools. It serves viral surveillance and inherited disease labs with overlapping catalog offerings.

TypeEmerging player
Description

Watchmaker Genomics is Molecular Loop's strategic manufacturing partner and a fellow emerging player in NGS enzymes and library prep. Both companies serve targeted-sequencing and viral surveillance labs, with Watchmaker overlapping in enzymes and high-stringency assay chemistry.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Molecular Loop

NGS Target Capture Reagentsmolecularloop.com

Molecular Loop develops and sells LoopCap™ molecular inversion probe-based targeted NGS reagent kits, serving infectious disease surveillance labs, academic genomic researchers, and reference labs (including Labcorp) with pathogen capture kits and custom panel design services.

What Molecular Loop does

Molecular Loop Biosciences, Inc. is a private Woburn, Massachusetts-based biotechnology company (founded 2018, 11–50 employees) that develops and sells targeted next-generation sequencing (NGS) reagents built around its proprietary LoopCap™ molecular inversion probe (MIP) chemistry. LoopCap combines target capture and library preparation into a single-tube, 4-step workflow with roughly 75 minutes of hands-on time and uses redundant probe tiling with non-overlapping priming sites to provide variant resilience against rapidly mutating pathogens. The company sells predesigned Viral RNA Target Capture Kits (SARS-CoV-2, RSV A/B, Hantavirus, Flu A/B incl. H5N1, HIV-2, Measles, Mumps, Powassan/deer tick virus, pan-viral/respiratory surveillance), a Viral DNA Target Capture Kit (mpox), an Inherited Disease research line, custom panel design services, and required Index Primer accessory kits, with products supporting Illumina, PacBio, and Oxford Nanopore sequencing platforms.

The business model is primarily a one-time-purchase NGS reagent sale priced at $7,815 per 96-reaction capture kit, $835 per Index Primer plate, and $3,000 per custom panel design unit, distributed through a direct e-commerce storefront at molecularloop.com with FedEx overnight cold-chain shipping. Distribution is supplemented by an exclusive Canadian agreement with D-MARK Biosciences (April 2023) and a manufacturing partnership with Watchmaker Genomics (May 2021) for enzyme formulations and scaled production. Marketing is anchored on conference participation (ASHG, AMP, AGBT, AACR, ACMG, APHL), the company website, and PRNewswire-distributed press releases.

Molecular Loop's customers include reference labs (notably Labcorp, which deployed its SARS-CoV-2 Research Sequencing Panel for CDC-affiliated surveillance), academic medical centers (Stanford, UC Davis, Northern Arizona University), and genomics research institutions (New York Genome Center, TGen North). The company remains Research Use Only, has not pursued diagnostic claims, and has secured a $1.8M Bill & Melinda Gates Foundation grant (December 2023) to extend multi-pathogen surveillance products into low- and middle-income countries. Total disclosed funding is approximately $4.3M across a 2019 raise, a 2022 exempt securities offering (~$2.5M filed / ~$1.79M sold), and the 2023 Gates grant.

Molecular Loop firmographics

Firmographics
Name
Molecular Loop
Legal name
Molecular Loop Biosciences, Inc.
Website
https://molecularloop.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Molecular Loop develops and sells LoopCap™ molecular inversion probe-based targeted NGS reagent kits, serving infectious disease surveillance labs, academic genomic researchers, and reference labs (including Labcorp) with pathogen capture kits and custom panel design services.
Ownership category
akta.pro rank

Molecular Loop industry classification

Industry
Product category
NGS Target Capture Reagents
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)

Keywords

  • Targeted sequencing kits
  • NGS capture reagents
  • Molecular inversion probes
  • Pathogen surveillance panels
  • Custom NGS panels

Where Molecular Loop is headquartered

Location

Headquarters

HQ city
Woburn
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Molecular Loop business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

  1. NGS Capture Kit Sales: Molecular Loop sells targeted sequencing reagent kits (capture kits) primarily as one-time purchases. Products include Viral RNA Target Capture Kits, Viral DNA Target Capture Kits, and Custom Panel Design services. Kits are sold in 96-reaction pack sizes, priced per kit. Additional accessories such as Index Primer Kits are sold separately.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goViral RNA Target Capture Kits (predesigned panels)
Unit PricingPay-as-you-goViral DNA Target Capture Kits
Unit PricingPay-as-you-goCustom Panel Design
Unit PricingPay-as-you-goIndex Primer Kits (UDI plates)

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Molecular Loop product offering

Product offering

Core offering

Molecular Loop develops and sells targeted next-generation sequencing (NGS) reagent kits built on its proprietary LoopCap molecular inversion probe (MIP) chemistry, which combines target capture and library preparation into a single-tube workflow. The product line consists of predesigned Viral RNA and Viral DNA Target Capture Kits for specific pathogens (SARS-CoV-2, RSV A/B, influenza incl. H5N1, mpox, HIV-2, measles, mumps, hantavirus, Powassan, and pan-viral/respiratory surveillance panels), required Index Primer Kit accessories, and a Custom Panel Design service for viral genomes and germline targets.

Product overview

Molecular Loop offers a portfolio of targeted NGS products centered on its proprietary LoopCap™ technology, which combines target capture and library preparation into a simplified 4-step workflow. The core offering includes pre-designed Viral RNA and DNA Target Capture Kits for specific pathogens (SARS-CoV-2, RSV A/B, Hantavirus, influenza variants including H5N1, HIV-2, Measles, Mumps, Powassan/deer tick virus, mpox) and a Pan-Viral/Respiratory Virus Surveillance Panel for multi-pathogen detection. Custom panel design services allow customers to create tailor-made assays for any viral genome or germline targets. Products are available for Illumina, PacBio, and Oxford Nanopore sequencing platforms. Required accessories include Index Primer Kits for multiplexing. The company also offers Inherited Disease research panels with flexible sizing from few targets to hundreds of genes.

Differentiator

Problem solved

Functional benefit

Products and services

  • Viral RNA Target Capture Kit, SARS-CoV-2, Illumina

Quantifiable outcome

  • 96% on-target rate achieved on first-pass design of a 1 Mbp panel covering 339 full genes including 5' UTRs
  • +4 more outcomes

Companies that use Molecular Loop

Customer profile

Named customers6 records

Segments2 records

Ideal customer profiles3 records

Molecular Loop technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Molecular Loop partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • D-MARK BiosciencescoreChannel Partner/ Reseller/ Distributor · 10 April 2023Exclusive distribution agreement making D-MARK Biosciences the sole distributor of LoopCap technology throughout Canada. D-MARK is a leading distributor of Genomic Workflow products and services in Canada with extensive relationships with genomic scientists and a strong reputation in the scientific research community.
  • Watchmaker GenomicscoreTechnology or Integration · 4 May 2021Partnership to accelerate commercialization of streamlined, high-stringency genetic testing for pathogen surveillance. Watchmaker brings expertise in computational biology, high-throughput enzyme engineering, and large-scale enzyme production to further enable Molecular Loop's advanced assay technologies. The collaboration enabled the launch of Molecular Loop's comprehensive SARS-CoV-2 Research Panel with customized enzyme formulations and scaled manufacturing.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Molecular Loop competitors and assessment

Company assessment

Broad incumbents

  • Roche: Roche — through Roche Molecular Diagnostics (former employer of Molecular Loop board member Paul Brown) — is a broad incumbent in molecular diagnostics and NGS-based clinical assays. It does not directly sell targeted NGS capture kits at research scale but represents the eventual clinical-diagnostics competitor Molecular Loop might face or partner with.
  • Illumina: Illumina dominates the sequencing platform layer that Molecular Loop's kits feed into (Illumina, alongside PacBio and ONT). Illumina also offers AmpliSeq and other library prep reagents that overlap with LoopCap's amplicon/capture use cases, making it both an ecosystem enabler and competitor.
  • QIAGEN: QIAGEN offers a broad portfolio of sample prep, target enrichment (QIAseq), and NGS reagent kits serving the same infectious disease and inherited disease research customers as Molecular Loop. It overlaps with Molecular Loop's library prep and capture workflows as part of a much broader life-science tools portfolio.
  • Thermo Fisher Scientific: Thermo Fisher's Ion Torrent sequencing and Applied Biosystems/Invitrogen reagents for NGS library prep and target enrichment compete in the same RUO research workflow as Molecular Loop's kits, though as part of an enormously broader life-sciences portfolio.
  • PerkinElmer / Revvity: Revvity (formerly PerkinElmer's life sciences business) supplies genomics reagents, including target enrichment and library prep kits, alongside broader life-science tools. It serves viral surveillance and inherited disease labs with overlapping catalog offerings.

Direct peers

  • Integrated DNA Technologies (IDT): IDT (a Danaher company) sells the xGen suite of hybridization capture and library prep reagents for targeted NGS. Its research-use kits for viral surveillance (including SARS-CoV-2) and germline panels compete head-to-head with Molecular Loop's viral capture kits.
  • Agilent Technologies: Agilent's SureSelect target-enrichment platform is a leading NGS capture chemistry used in inherited disease, oncology, and infectious disease research. Molecular Loop competes with SureSelect on customizable, scalable targeted sequencing panels for similar end customers.
  • Twist Bioscience: Twist develops synthetic DNA-based target enrichment and library preparation kits for NGS workflows sold to research and clinical labs. Both companies sell NGS capture panels to infectious disease and inherited disease researchers, making Twist the closest direct peer to Molecular Loop's LoopCap kits.
  • New England Biolabs (NEB): NEB's NEBNext product line covers DNA and RNA library prep and target enrichment reagents used by the same research and clinical genomics labs as Molecular Loop. Both vendors supply RUO capture and library prep kits for viral pathogen sequencing.

Emerging players

  • Watchmaker Genomics: Watchmaker Genomics is Molecular Loop's strategic manufacturing partner and a fellow emerging player in NGS enzymes and library prep. Both companies serve targeted-sequencing and viral surveillance labs, with Watchmaker overlapping in enzymes and high-stringency assay chemistry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Molecular Loop social profiles

Digital presence

Molecular Loop financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Molecular Loop leadership team

Management profile

Number of profiles

Profiles4 records

Molecular Loop funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Molecular Loop M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molecular Loop

What does Molecular Loop do?

Molecular Loop develops and sells targeted next-generation sequencing (NGS) reagent kits built on its proprietary LoopCap molecular inversion probe (MIP) chemistry, which combines target capture and library preparation into a single-tube workflow. The product line consists of predesigned Viral RNA and Viral DNA Target Capture Kits for specific pathogens (SARS-CoV-2, RSV A/B, influenza incl. H5N1, mpox, HIV-2, measles, mumps, hantavirus, Powassan, and pan-viral/respiratory surveillance panels), required Index Primer Kit accessories, and a Custom Panel Design service for viral genomes and germline targets.

Is Molecular Loop a public or private company?

Molecular Loop is a private company. It is classified as venture growth investor backed and is currently operating.

When was Molecular Loop founded?

Molecular Loop was founded in 2018. It employs 1 to 10 people.

Where is Molecular Loop based?

Molecular Loop is headquartered in Woburn, United States, in the North America region.

How does Molecular Loop make money?

One revenue line is on record: NGS Capture Kit Sales.

Who are Molecular Loop's main competitors?

Broad incumbents on record are Roche, Illumina, QIAGEN, Thermo Fisher Scientific and PerkinElmer / Revvity. Direct peers are Integrated DNA Technologies (IDT), Agilent Technologies, Twist Bioscience and New England Biolabs (NEB). Watchmaker Genomics is listed as an emerging player.

Does Molecular Loop have an API?

No public API is recorded for Molecular Loop.

What industry is Molecular Loop in?

Molecular Loop's product category is NGS Target Capture Reagents. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireMolecular Loop Biosciences Receives $1.8 Million to Expand Multi-pathogen Genomics Products for Respiratory InfectionsMolecular Loop Biosciences received a $1.8 million grant from the Bill & Melinda Gates Foundation to expand its multi-pathogen genomics products for respiratory infections. The funding will support the development of a next-generation sequencing assay aimed at improving infectious disease surveillance in low- and middle-income countries. This initiative seeks to overcome technical barriers in pathogen sequencing to empower laboratories in resource-limited settings.MolecularloopMolecular Loop Biosciences Receives $1.8 Million to Expand Multi-pathogen Genomics Products for Respiratory InfectionsMolecular Loop Biosciences received a $1.8 million grant from the Bill & Melinda Gates Foundation to expand its multi-pathogen genomics products for respiratory infections. The funding will support the development of a next-generation sequencing assay aimed at improving pathogen surveillance capabilities in low- and middle-income countries.FinSMEsMolecular Loop Biosciences Receives $1.8M GrantMolecular Loop Biosciences received a $1.8 million grant from the Bill & Melinda Gates Foundation to develop a multiplex NGS assay for analyzing respiratory infection pathogens. The company intends to use this funding to tailor customized targeted sequencing solutions that support viral surveillance efforts in low- and middle-income countries.PR NewswireMolecular Loop Appoints Paul Brown, Ph.D. to its Board of DirectorsMolecular Loop Biosciences appointed genomics and molecular diagnostics veteran Paul Brown, Ph.D. to its board of directors on May 16, 2023. Brown previously served as Head of Roche Molecular Solutions before retiring from Roche in 2020, bringing extensive experience in commercializing genomics offerings across virology, blood screening, infectious diseases, oncology, and sequencing solutions. The company stated that Brown's appointment is intended to help accelerate growth and expand market reach as Molecular Loop works to make genetic testing more accessible to laboratories worldwide.SecSEC FORM DMolecular Loop Biosciences, Inc. filed a new notice of exempt offering of securities with the SEC. The offering is intended to raise a total amount of $2,500,000, with $1,793,438 already sold and $706,562 remaining to be sold.PR NewswireLabcorp Adopts Molecular Loop SARS-CoV-2 Research Sequencing Panel for Large-Scale Viral SurveillanceLabcorp has adopted Molecular Loop Biosciences' SARS-CoV-2 Research Sequencing Panel to sequence thousands of complete coronavirus genomes each week from positive patient samples. This sequencing is being performed as part of a U.S. Centers for Disease Control and Prevention effort to track the spread of SARS-CoV-2 variants throughout the country. The Molecular Loop panel uses a four-step workflow with redundant probe tiling technology that enables detection of emerging variants while minimizing amplicon dropouts.